Volume 75, Issue 1, Pages (January 2009)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Volume 80, Issue 1, Pages (July 2011)
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 1, Pages (January 2003)
Volume 85, Issue 2, Pages (January 2014)
Volume 82, Issue 11, Pages (December 2012)
Volume 76, Issue 5, Pages (September 2009)
Volume 69, Issue 10, Pages (May 2006)
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Glomerulus number and blood pressure in the Prague hypertensive rat
Volume 83, Issue 5, Pages (May 2013)
Volume 65, Issue 1, Pages (January 2004)
Prehypertension and chronic kidney disease: the ox or the plow?
Volume 68, Issue 5, Pages (November 2005)
Volume 58, Issue 6, Pages (December 2000)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 63, Issue 6, Pages (June 2003)
Volume 68, Issue 3, Pages (September 2005)
Volume 68, Issue 1, Pages (July 2005)
Volume 59, Issue 5, Pages (May 2001)
Volume 54, Issue 5, Pages (November 1998)
Volume 76, Issue 3, Pages (August 2009)
Mohammed S. Razzaque, Ph.D., Takashi Taguchi  Kidney International 
Comorbidity and confounding in end-stage renal disease
Volume 60, Issue 6, Pages (December 2001)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 87, Issue 2, Pages (February 2015)
Targets to retard the progression of diabetic nephropathy
Volume 70, Issue 3, Pages (August 2006)
Volume 66, Issue 3, Pages (September 2004)
Volume 79, Issue 4, Pages (February 2011)
Volume 69, Issue 3, Pages (February 2006)
Volume 68, Issue 1, Pages (July 2005)
Blood pressure targets in hemodialysis patients
Volume 76, Issue 5, Pages (September 2009)
Volume 62, Issue 3, Pages (September 2002)
Volume 71, Issue 7, Pages (April 2007)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 59, Issue 4, Pages (April 2001)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 71, Issue 9, Pages (May 2007)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 63, Pages S38-S42 (February 2003)
Volume 78, Issue 1, Pages (July 2010)
Volume 80, Issue 5, Pages (September 2011)
Angiotensin II production and distribution in the kidney – II
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Volume 87, Issue 1, Pages (January 2015)
Volume 68, Issue 4, Pages (October 2005)
Volume 64, Issue 6, Pages (December 2003)
Tatsumi Moriya, Thomas J. Groppoli, Youngki Kim, Michael Mauer 
Volume 80, Issue 3, Pages (August 2011)
Volume 57, Issue 5, Pages (May 2000)
Fibrosis and renal aging
Volume 58, Issue 3, Pages (September 2000)
Volume 64, Issue 2, Pages (August 2003)
The treatment of acute interstitial nephritis: More data at last
Amylin deposition in the kidney of patients with diabetic nephropathy
Inhibition of the renin–angiotensin system: is more better?
Volume 73, Issue 5, Pages (March 2008)
Volume 58, Issue 2, Pages (August 2000)
Effect of prenatal dexamethasone on rat renal development
Volume 64, Issue 6, Pages (December 2003)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 57, Issue 2, Pages (October 2000)
Lipoprotein abnormalities in diabetic nephropathy
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Volume 79, Issue 10, Pages (May 2011)
Volume 70, Issue 1, Pages (July 2006)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 75, Issue 1, Pages 72-79 (January 2009) Regression of glomerular injury by losartan in experimental diabetic nephropathy  Flávio Teles, Flávia G. Machado, Bianca H. Ventura, Denise M.A.C. Malheiros, Clarice K. Fujihara, Luís F.F. Silva, Roberto Zatz  Kidney International  Volume 75, Issue 1, Pages 72-79 (January 2009) DOI: 10.1038/ki.2008.528 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Blood glucose, tail-cuff and albuminuria. (a) Time course of blood glucose concentration, (b) tail-cuff pressure, and (c) albuminuria in groups C (filled circles), DMPRE (open circles), DMUNT (open squares), DML50 (filled squares), and DML500 (filled triangles). Treatment was given only during the period represented by the shaded area (from 10 to 12 months of DM). Group DMPRE was followed until 10 months of DM only. No significant difference among groups was observed regarding BG, TCP, or UalbV before the treatment period. aP<0.05 versus C, bP<0.05 versus 10-month (pretreatment) value, and cP<0.05 versus DMUNT. Kidney International 2009 75, 72-79DOI: (10.1038/ki.2008.528) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Histological studies. (a, b) Representative glomeruli, stained by the PAS reaction, illustrating mesangial expansion (a) and segmental sclerotic lesions (b) at the end of the study (12 months of DM). (c) Bar graph representation of the mesangial fractional areas at 12 months of DM, (d) bar graph representation of the glomerulosclerosis index (measuring frequency and extent of segmental sclerotic lesions) at 12 months of DM, and (e) bar graph representation of the frequency of glomeruli with sclerotic injury (% glomeruli with segmental sclerotic lesions) at 12 months of DM. aP<0.05 versus C, bP<0.05 versus respective 10-month (pretreatment) value, and cP<0.05 versus DMUNT. Kidney International 2009 75, 72-79DOI: (10.1038/ki.2008.528) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Macrophage infiltration of renal tissue. (a and b) Representative glomeruli illustrating the expression of the macrophage-specific ED-1 antigen at glomerular (a) and interstitial (b) areas. (c and d) Bar graphs showing the quantitative analysis of the expression of glomerular and interstitial ED-1, respectively. aP<0.05 versus C, bP<0.05 versus DMPRE (pretreatment), and cP<0.05 versus DMUNT. Kidney International 2009 75, 72-79DOI: (10.1038/ki.2008.528) Copyright © 2009 International Society of Nephrology Terms and Conditions